your market intelligence analyst
Search Results
113 results
Your search is now limited to «Respiratory Diseases Research and Pipeline» expert search.
European Respiratory Journal 10/10/2019 09:13
A prospective cohort of persistent asthma patients in France and the United Kingdom (N=847, age 6−40 years) provided 3756 reports over up to 2 years via computer-assisted telephone interviews and text messages on ICS adherence, asthma control, reliever medication use, and exacerbations ...
More from European Respiratory Journal: 10/10/2019 08:47
Condition : Copd Intervention : Other: observatory Sponsor : Prince of Songkla University Completed.
More from
COPD News Today 10/08/2019 13:00
Michael J. Holtzman, MD, has received close to $7.5 million in total funding for research aimed at developing stem cell-based treatments for chronic obstructive pulmonary disease (COPD), asthma, and other disorders.
More from COPD News Today: 10/07/2019 18:29
Coraline Radermecker, the first author of the study, first developed three models of asthma in mice induced by pro-allergic environments: excess hygiene, exposure to ozone (an air pollutant) and infection with the influenza virus.
More from
A third of patients with severe asthma are taking harmful doses of oral steroids, according to a study of several thousand people in the Netherlands, presented this week at the European Respiratory Society International Congress.
More from RT: For Decision Makers in Respiratory Care:
PR Newswire 10/01/2019 03:00
... safety of two different doses of IND/GLY/MF (150/50/80 μg and 150/50/160 μg) versus two respective IND/MF doses (150/160 μg and 150/320 μg) in uncontrolled patients with asthma, as determined by pulmonary function testing and effects on asthma control.
More from PR Newswire:
Our objective was to conduct a study that provides data on the level of symptom control and the frequency of specific risk factors for poor asthma outcomes on a large patient cohort.
More from International Journal of COPD:
BioNewsFeeds 09/20/2019 11:00
The findings were reported in the study, “Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry – A single-centre feasibility study,” published recently in the journal PLOS One.
More from BioNewsFeeds:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications